Helicobacter pylori-induced STAT3 activation and signalling network in gastric cancer

10.18632/oncoscience.62Oncoscience16468-47

Quantificação de transcritos maternos em oócitos bovinos submetidos a diferentes condições de maturação

Comparou-se a quantidade relativa de transcritos de origem materna entre oócitos bovinos maturados in vivo e maturados em diferentes condições in vitro. Avaliou-se também o efeito dos sistemas de maturação in vitro sobre a viabilidade das células do cumulus. Para a maturação in vivo, os oócitos foram coletados 19-20h após aplicação de gonadorelina em doadoras superestimuladas com FSH e sincronizadas com implante de progesterona. Para a maturação in vitro, oócitos imaturos, obtidos de ovários coletados em matadouro, foram maturados sob diferentes tensões de oxigênio e suplementação proteica. Avaliou-se a abundância dos transcritos de Zar1, MATER e GDF9 por PCR em tempo real. A viabilidade das células do cumulus de oócitos maturados in vitro foi analisada pela coloração de Azul de Tripan. Observou-se sub-regulação (P<0,05) dos transcritos em oócitos submetidos às diferentes condições de maturação in vitro em relação aos maturados in vivo. Não houve diferença (P>0,05) na viabilidade das células do cumulus. Conclui-se que o sistema de maturação influencia a quantidade de transcritos de origem materna armazenados no citoplasma de oócitos bovino

Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996 2014: Results from a national observational cohort

Objectives: Early testing for HIV and entry into care are crucial to optimise treatment outcomes of HIV-infected patients and to prevent spread of HIV. We examined risk factors for presentation with late or advanced disease in HIV-infected patients in the Netherlands. Methods: HIV-infected patients registered in care between January 1996 and June 2014 were selected from the ATHENA national observational HIV cohort. Risk factors for late presentation and advanced disease were analysed by multivariable logistic regression. Furthermore, geographical differences and time trends were examined. Results: Of 20 965 patients, 53% presented with latestage HIV infection, and 35% had advanced disease. Late presentation decreased from 62% (1996) to 42% (2013), while advanced disease decreased from 46% to 26%. Late presentation only declined significantly among men having sex with men (MSM; p <0.001), but not among heterosexual males (p=0.08) and females (p=0.73). Factors associated with late presentation were: heterosexual male (adjusted OR (aOR), 1.59; 95% CI 1.44 to 1.75 vs MSM), injecting drug use (2.00; CI 1.69 to 2.38), age .50 years (1.46; CI 1.33 to 1.60 vs 30.49 years), region of origin (South-East Asia 2.14; 1.80 to 2.54, sub-Saharan Africa 2.11; 1.88 to 2.36, Surinam 1.59; 1.37 to 1.84, Caribbean 1.31; 1.13 to 1.53, Latin America 1.23; 1.04 to 1.46 vs the Netherlands), and location of HIV diagnosis (hospital 3.27; 2.94 to 3.63, general practitioner 1.66; 1.50 to 1.83, antenatal screening 1.76; 1.38 to 2.34 vs sexually transmitted infection clinic). No association was found for socioeconomic status or level of urbanisation. Compared with Amsterdam, 2 regions had higher adjusted odds and 2 regions had lower odds of late presentation. Results were highly similar for advanced disease. Conclusions: Although the overall rate of late presentation is declining in the Netherlands, targeted programmes to reduce late HIV diagnoses remain needed for all risk groups, but should be prioritised for heterosexual males, migrant populations, people aged ≥50 years and certain regions in the Netherlands